What is UNOV's market cap?

$106.51M, based on the Sep 28 close of $41.36.

What is UNOV's P/E ratio?

27.4× trailing-twelve-month earnings of $3.89M.

What sector is UNOV in?

Healthcare, in the Pharmaceuticals industry.

Cboe BZX · UNOVHealthcarePharmaceuticals

Innovator U.S. Equity Ultra Buffer ETF - November (UNOV)

$41.36−0.24%

Close Sep 28, 2026 · split-adjusted

Sep 28, 2026$41.36▲ 10.36% in range

Sep 29, 2025Low $36.78 · High $41.47Sep 28, 2026

What changed · written from our data

As of Sep 28, 2026

Innovator U.S. Equity Ultra Buffer ETF - November closed at $41.36 on Sep 28, down 0.24%, 0.3% below its 52-week closing high. Volume of 4.4K shares was 0.77× its 20-day average (below normal).

Split-adjusted performance: +0.6% over one month, +12.4% over six months, +10.7% over one year.

In the quarter ended Jun 30, 2026, revenue was $9.03M, up 3.0% from a year earlier, with a net margin of 8.0%.

Short interest was 369 shares at the Sep 15 settlement (1.0 days to cover).

Market cap$106.5M2.6M shares

Revenue · quarter$9.0M+3.0% YoY

Diluted EPS$0.00—

P/E · TTM27.4×P/S 3.0×

Net margin8.0%Gross 69.0%

Dividend yieldNone

52-week range36.78 – 41.47−0.3% from high

Volume4.4K0.77× 20-day avg

Volatility · 60d5.1%Annualised

Short % of float—1.0 days to cover

Net cash$2.8MCash $2.8M

Next earnings—Not scheduled

Split-adjusted performance

1W −0.2%1M +0.6%3M +3.4%6M +12.4%YTD +8.7%1Y +10.7%3Y +35.3%5Y +41.4%

Earnings reactions

History →

No reported quarters with price history yet.

Rank within Pharmaceuticals

Percentile among 423 companies (100 = best)

6-month momentum—

Revenue growth—

Net margin—

Value (low P/E)—

Size—

Industry medians: 6-month return −2.9%, revenue growth +6.4%, net margin −41.2%, P/E 16.2×.

Short interest

Details →

Shares short3690.0% vs prior

Days to cover1.0Settled Sep 15

% of float—

Short vol. 10d19.1%of daily volume

Closest peers by size in Pharmaceuticals

Company	Price	Today	6M	Rev. growth	Net margin	P/E	Mkt cap
UNOVInnovator U.S. Equity Ultra Buffer ETF - November	$41.36	−0.24%	+12.4%	+3.0%	8.0%	27.4	$106.5M
CPSRCalamos S&P 500 Structured Alt Protection ETF - March	$26.19	+0.03%	+3.9%	−87.7%	−693.9%	—	$34.0M	Compare
EYEGAB Corporate Bond ETF	$33.45	−0.61%	−4.2%	—	—	—	$26.8M	Compare
EDGEMRBL Enhanced Equity ETF	$51.97	−0.54%	+22.6%	—	—	—	$12.5M	Compare

News about Innovator U.S. Equity Ultra Buffer ETF - November

All news →

No recent articles focused on Innovator U.S. Equity Ultra Buffer ETF - November.

Quick answers

What is UNOV's market cap?: $106.51M, based on the Sep 28 close of $41.36.
What is UNOV's P/E ratio?: 27.4× trailing-twelve-month earnings of $3.89M.
What sector is UNOV in?: Healthcare, in the Pharmaceuticals industry.

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology